Search Result for : Pharma Exports

No need of NOC for pharma exports: Govt

The Dollar Business Bureau In a bid to facilitate exports and make easier to do business, the Government on Wednesday eased the guidelines for drugs, medical devices and cosmetics exporters. Now the pharmaceutical companies will no longer have to get ‘no-objection’ certificate (NOC) from regulatory authority to export drugs and medical devices. “The pharmaceutical exporters can continue exporting without having to obtain no-objection certificates (NOC) from the regulatory authorities,” said the Central Drugs Standard Control Organisation (CDSCO) in a notice. Earlier, this facility was only available for exports to Australia, US, Japan, Canada, and European Union. Now CDSCO has extended the rule for exports to all other countries. “In partial modification of notice of even number dated December 11, 2015, removing the requirement of NOC for ...

India rejected 955 pharma patent applications in last 3 years: Sitharaman

The Dollar Business Bureau  India has rejected 955 patent applications in the pharmaceutical sector during the last three years. "... 618 applications have been rejected citing Section 3 (d) of the Patents Act, 1970, as one of the grounds for rejection in the last three years," Commerce and Industry Minister Nirmala Sitharaman said in a written reply to the Lok Sabha today. "A total of 955 patent applications in pharma have been rejected by the Indian Patent Office (IPO) in the last three years," she said.  Sitharaman said India is considered as a leading exporter and currently holds second position in outbound shipments of generic drugs.  Replying to a separate query, the commerce minister said exports from SEZs have witnessed a slowdown due to the withdrawal of ...

Madan Mohan Reddy takes charge as Pharmexcil Chairman

Sharath Chowdary Aurobindo Pharma’s whole time Director Madan Mohan Reddy has assumed charge as Chairman of Pharmaceuticals Export Promotion Council of India (Pharmexcil), as announced during the 65th annual meeting of Committee of Administration (CoA) in Hyderabad on Friday. He was elevated to the present post after serving for two years as Vice Chairman of Pharmexcil.   Madan Mohan Reddy, a post-graduate in organic chemistry, has more than 25 years of experience in the pharma industry. He has worked in several senior management positions in top pharma companies. For the past ten years, manufacture of formulations at Aurobindo was his forte. Prior to this, he was the Managing Director of Srichakra Remedies Ltd. Pharmexcil will soon fill the post of Vice-Chairman from the newly elected COA members. ...

Sun Pharma to sell 2 plants to Frontida BioPharm

The Dollar Business Bureau Sun Pharmaceutical on Monday announced that it is planning to sell its two oral solid dosage manufacturing plants to Frontida BioPharm Inc in the United States. “Frontida has agreed to continue manufacturing certain products for Sun Pharma at these facilities on a contract basis for a predetermined period. It has also agreed to offer employment to all production, quality and administrative personnel at the sites,” Gurgaon-based pharma company said in a statement. “The effect of this deal on Sun Pharmaceutical’s overall financials and activities is not material,” it added. The drug major also stated it was aware about ensuring the continued supply of quality products to patients during the divestment process. This is the second divestment ...

Indian drug firms to see moderation in growth in US

The Dollar Business Bureau Rating agency ICRA on Thursday said that the Indian pharmaceutical industry will witness moderation in growth due to slow down of business in the US with a decline in the volume of large size drugs going off patent, increasing competition and adoption of generics reaching a saturation level. Over the last 10 years, the Indian pharmaceutical companies have witnessed a strong growth driven largely by the US market. "However, the growth from the US market has been down to 15 percent in financial year 2015-16 and looking forward the momentum for growth is possibly to face more pressure," ICRA (Investment Information and Credit Rating Agency of India) said in a statement. The Indian drug companies will have an impact on ...

Pharmexcil to get new Chairman, Vice Chairman

Sairaj Aiyyar   Pharmexcil will soon be headed by a new Chairman and Vice-Chairman, to govern the 6th committee of administration. A formal notification on the Pharmaceutical Export Promotion Council’s (Pharmexcil) website pointed out to an impending election notification, and sought nominations from its members. This is in line with the Commerce ministry’s regulations that took some time due to various internal issues. But this development is a self-inspired one, as the notification on its website explains in detail.The notification details how the council is acting on a letter dated 7th December 2015 from the Ministry of Commerce, which directs the council to follow election guidelines and comply with para 2.92 of the Foreign Trade Policy handbook before 31st March 2016. Para ...

India wary of EU seizing Indian drugs

The Dollar Business Bureau As the new European Union trademark law has been passed without considering any of the suggestions India has made, now the country is weighing its options in case the EU seizes its pharmaceutical exports to the third world countries. According to a source from Commerce Ministry, the country will not hesitate to knock the doors of World Trade Organization. It is pursuing the issue bilaterally as it does not want any uncertainty. He also said that the EU is ready to discuss the matter with India to have a broader dialogue on Intellectual Property Rights. As per the stringent enforcement provisions of new trademark legislation, customs officials can seize international consignments destined to third countries if they have brand ...

India needs to augment its medical device sector along with pharma

 Sachin Manawaria | The Dollar Business The task force constituted by the government to look into difficulties faced by the medical devices sector in India will come out with its recommendation in two months’ time, according to the V.K. Subburaj, Secretary, Department of Pharmaceuticals. Speaking at an event held recently by the Associated Chambers of Commerce & Industry of India (ASSOCHAM), V.K. Subburaj said that the overall medical equipment industry in India stands at around $5 billion compared to the global size of around $200 billion. There is a need to build a conducive environment and rationalise the tax structure to help India’s medical equipment sector grow, he added. India is considered as a leader at global level in ...